These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37753441)

  • 1. Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients.
    Adil SO; Uddin F; Musa KI; Khan A; Shakeel A; Shafique K; Islam MA
    Int J Gen Med; 2023; 16():4295-4305. PubMed ID: 37753441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk assessment among type-2 diabetic subjects in selected areas of Bangladesh: concordance among without cholesterol-based WHO/ISH, Globorisk, and Framingham risk prediction tools.
    Mondal R; Ritu RB; Banik PC
    Heliyon; 2021 Aug; 7(8):e07728. PubMed ID: 34401593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the Framingham risk score for prediction of metabolic syndrome: The Kerman Coronary Artery Disease Risk Study, Iran.
    Yousefzadeh G; Shokoohi M; Najafipour H; Shadkamfarokhi M
    ARYA Atheroscler; 2015 May; 11(3):179-85. PubMed ID: 26405450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2020 Mar; ():2047487320906650. PubMed ID: 32122200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
    Gurka MJ; Filipp SL; Pearson TA; DeBoer MD
    J Am Heart Assoc; 2018 Aug; 7(16):e009754. PubMed ID: 30369320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.
    Muhammed H; Misra DP; Jain N; Ganguly S; Pattanaik SS; Rai MK; Anuja AK; Mohindra N; Kumar S; Agarwal V
    Clin Rheumatol; 2022 Dec; 41(12):3675-3686. PubMed ID: 36006556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
    Zhang XL; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Holman RR; Yuan SY;
    Diabetes Ther; 2020 Apr; 11(4):885-903. PubMed ID: 32086768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of cardiovascular disease risk factors and the Framingham Risk Score in patients undergoing percutaneous intervention over the last 17 years by gender: time-trend analysis from the Mayo Clinic PCI Registry.
    Lee MS; Flammer AJ; Kim HS; Hong JY; Li J; Lennon RJ; Lerman A
    J Prev Med Public Health; 2014 Jul; 47(4):216-29. PubMed ID: 25139168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framingham Risk Score and Estimated 10-Year Cardiovascular Disease Risk Reduction by a Short-Term Yoga-Based LifeStyle Intervention.
    Yadav R; Yadav RK; Sarvottam K; Netam R
    J Altern Complement Med; 2017 Sep; 23(9):730-737. PubMed ID: 28437144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores.
    Mora S; Redberg RF; Sharrett AR; Blumenthal RS
    Circulation; 2005 Sep; 112(11):1566-72. PubMed ID: 16144993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
    Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
    BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.
    Schoofs MC; Akkermans RP; de Grauw WJ; Schalk BW; van Dis I; Tjin-A-Ton J; Bischoff EW; Biermans MC
    Br J Gen Pract; 2023 Jan; 73(726):e24-e33. PubMed ID: 36443066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Syndrome and Framingham Risk Score: Observation from Screening of Low-Income Semi-Urban African Women.
    Dada AS; Ajayi DD; Areo PO; Raimi TH; Emmanuel EE; Odu OO; Aremu OA
    Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930125
    [No Abstract]   [Full Text] [Related]  

  • 15. High sensitivity C-reactive protein (hsCRP): Its relationship with metabolic syndrome and Framingham Risk Score.
    Zahari Sham SY; Hanif E; Thambiah SC; Samsudin IN; Mohd Noor S; Osman M; Abdullah H; Mustaffa K
    Malays J Pathol; 2021 Apr; 43(1):33-40. PubMed ID: 33903303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome.
    Jahangiry L; Farhangi MA; Rezaei F
    J Health Popul Nutr; 2017 Nov; 36(1):36. PubMed ID: 29132438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of fruit and vegetable intake with predicted 10-year cardiovascular disease risk among hypertensive patients in Addis Ababa, Ethiopia: a cross-sectional study.
    Mekonene M; Gebremedhin S; Bikila D; Ashebir G; Baye K
    BMJ Open; 2023 Aug; 13(8):e075893. PubMed ID: 37640463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort.
    Zibaeenezhad MJ; Sayadi M; Karimi-Akhormeh A; Ardekani A; Parsa N; Razeghian-Jahromi I
    BMJ Open; 2022 Feb; 12(2):e058333. PubMed ID: 35168988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score.
    Huang JC; Chen SC; Lin MY; Chang JM; Hwang SJ; Tsai JC; Chen HC
    PLoS One; 2014; 9(5):e96362. PubMed ID: 24804770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between metabolic syndrome and 10-year risk of developing cardiovascular disease in a Nigerian population.
    Oguoma VM; Nwose EU; Skinner TC; Richards RS; Digban KA; Onyia IC
    Int Health; 2016 Sep; 8(5):354-9. PubMed ID: 27118483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.